<p>AstraZeneca Chief Executive Pascal Soriot said on Friday the company is "very encouraged" by interim data from a key lung cancer drug trial, but he did not explain why the company had not declared results as "clinically meaningful".</p>.<p>The drugmaker's shares fell by as much as 8 per cent earlier this month after the company released interim data from the late-stage clinical trial called TROPION-Lung01 testing an experimental precision drug called datopotamab deruxtecan.</p>.<p>At the time, investors were disappointed the company did not say the data was "clinically meaningful", a potential suggestion that the benefits may not be as pronounced as hoped.</p>.<p><strong>Read | <a href="https://www.deccanherald.com/national/indian-made-cough-syrup-sent-to-iraq-contains-toxic-chemicals-test-shows-1241541.html">Indian-made cough syrup sent to Iraq contains toxic chemicals, test shows</a></strong></p>.<p>Speaking to media on Friday after the company released better-than-expected quarterly results, Soriot said people would understand when full results are released why the company did not use that description, but he did not comment further.</p>.<p>"We are very encouraged because we're seeing the totality of the data," he said, adding that the company had described them as "statistically positive".</p>.<p>Executives on the briefing would not say when final data will be released or at which medical conference. </p>
<p>AstraZeneca Chief Executive Pascal Soriot said on Friday the company is "very encouraged" by interim data from a key lung cancer drug trial, but he did not explain why the company had not declared results as "clinically meaningful".</p>.<p>The drugmaker's shares fell by as much as 8 per cent earlier this month after the company released interim data from the late-stage clinical trial called TROPION-Lung01 testing an experimental precision drug called datopotamab deruxtecan.</p>.<p>At the time, investors were disappointed the company did not say the data was "clinically meaningful", a potential suggestion that the benefits may not be as pronounced as hoped.</p>.<p><strong>Read | <a href="https://www.deccanherald.com/national/indian-made-cough-syrup-sent-to-iraq-contains-toxic-chemicals-test-shows-1241541.html">Indian-made cough syrup sent to Iraq contains toxic chemicals, test shows</a></strong></p>.<p>Speaking to media on Friday after the company released better-than-expected quarterly results, Soriot said people would understand when full results are released why the company did not use that description, but he did not comment further.</p>.<p>"We are very encouraged because we're seeing the totality of the data," he said, adding that the company had described them as "statistically positive".</p>.<p>Executives on the briefing would not say when final data will be released or at which medical conference. </p>